After a very strong five year run, Manulife Financial now screens as roughly fairly valued on headline multiples. This makes the recent share gains harder to call a clear bargain or a clear stretch.

• Manulife Financial has returned about 208.3% over the past five years, which puts extra focus on whether the current price still leaves much upside for new investors.
• The recent 16% rise in core earnings and the long term care reinsurance deal with Munich Re can support confidence in the business. At the same time, the planned transfer of biometric risk also highlights how legacy liabilities may still influence how investors think about valuation.
• The stock earns a mixed valuation read, with 4 out of 6 checks suggesting it is neither an obvious bargain nor clearly overpriced.

For investors, the debate is whether Manulife Financial's strong past returns already reflect its fundamentals or whether there is still room for further value to be realised from here.

Manulife Financial delivered 55.1% returns over the last year. See how this stacks up to the rest of the Insurance industry.

Does Manulife Financial Look Fairly Valued on Earnings?

The P/E ratio is a useful way to compare Manulife Financial with other insurers because earnings are a key driver of value for this type of business. Right now, the stock trades on about 16.4x earnings, which is higher than the broader insurance industry average of about 12.1x, but below the peer group average of roughly 19.4x. That places Manulife in the middle of the pack, not obviously cheap or stretched on this simple comparison.

A more tailored fair P/E ratio for Manulife Financial, which blends factors like analyst expectations for returns on equity, margins and risk, comes out at about 18.1x. That is modestly above the current market multiple and suggests the shares sit close to what this framework treats as a balanced valuation. Despite the recent 16% rise in core earnings and the long term care reinsurance deal with Munich Re improving sentiment, the market P/E still values Manulife at only a slight discount to this fair multiple.

On the P/E measure, Manulife Financial looks roughly fairly valued with only a small gap between its current and modelled fair multiple.

See what the numbers say about this price — find out in our valuation breakdown.

The Manulife Financial Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Manulife Financial pick up where this valuation puzzle leaves off and explain what would need to happen to future growth, margins and earnings for the stock to be worth materially more or materially less than today's price. Each Narrative links a fair value to a specific story about Manulife Financial's potential catalysts and risks so you can track over time which version of events appears to be taking shape on the Community page.

Share a narrative on Manulife Financial and add your voice to the Simply Wall St community with a number-driven view on whether the recent 16% rise in core earnings and the C$3.2b long term care reinsurance deal with Munich Re support today's valuation. It is a way to set out your case now and see how it holds up as new results and updates emerge.

Do you think there's more to the story for Manulife Financial? Head over to our Community to see what others are saying!

The Bottom Line

Manulife Financial now sits in an about-right zone on market multiples, with its current P/E only slightly below the tailored fair ratio. That keeps the valuation debate finely balanced rather than clearly undervalued or overvalued. The central issue from here is whether core earnings and returns can keep justifying a mid pack multiple, especially as the market weighs legacy liabilities against recent reinsurance moves. For investors, the key question is whether any future shift in sentiment or earnings quality leads to a meaningful re rating or leaves the stock closer to a hold for existing positions than an obvious value opportunity.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.